AR
Anjali Rossi Ajaikumar
About Anjali Rossi Ajaikumar
Data last updated:
Anjali Rossi Ajaikumar is a Director at Healthcare Global Enterprises Limited (since 2021), Director at Sada Sharada Tumor And Research Institute (since 2018) and Director at Bacc Health Care Private Limited (since 2023), and holds 1 more current directorship. The companies operate in Healthcare and Other Industry. The 3 current companies with reported revenue have a combined latest revenue of ₹2,397 Cr; the largest is Healthcare Global Enterprises Limited at ₹2,258 Cr (FY 2025). Earlier, Anjali Rossi Ajaikumar was a Nominee Director at Suchirayu Health Care Solutions Limited (2021–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Healthcare Global Enterprises Limited L15200KA1998PLC023489 | Director | 01 Apr 2021 | 1998 | ₹2,258 Cr (FY 2025) | Active |
 Sada Sharada Tumor And Research Institute U85110KA1989NPL009862 | Director | 19 Mar 2018 | 1989 | ₹80.93 Cr (FY 2025) | Active |
 Bacc Health Care Private Limited U74140KA2002PTC030098 | Director | 02 Aug 2023 | 2002 | ₹58.38 Cr (FY 2025) | Active |
 Equator Games Llp AAV-1394 | Designated Partner | 17 Dec 2020 | 2020 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Suchirayu Health Care Solutions Limited U85110KA2011PLC056520 | Nominee Director | 18 Nov 2021 | 2011 | ₹97.77 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Anjali Rossi Ajaikumar
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anjali Rossi Ajaikumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anjali Rossi Ajaikumar
Anjali Rossi Ajaikumar currently holds 4 directorships: Healthcare Global Enterprises Limited (Director, since 01 Apr 2021, revenue ₹2,258 Cr (FY 2025)); Sada Sharada Tumor And Research Institute (Director, since 19 Mar 2018, revenue ₹80.93 Cr (FY 2025)); Bacc Health Care Private Limited (Director, since 02 Aug 2023, revenue ₹58.38 Cr (FY 2025)); Equator Games Llp (Designated Partner, since 17 Dec 2020).
Anjali Rossi Ajaikumar was first appointed on 19 Mar 2018 as Director at Sada Sharada Tumor And Research Institute. The most recent appointment on record is 02 Aug 2023 at Bacc Health Care Private Limited.
The 3 current companies of Anjali Rossi Ajaikumar that report revenue have a combined latest revenue of ₹2,397 Cr: Healthcare Global Enterprises Limited ₹2,258 Cr (FY 2025); Sada Sharada Tumor And Research Institute ₹80.93 Cr (FY 2025); Bacc Health Care Private Limited ₹58.38 Cr (FY 2025).
Anjali Rossi Ajaikumar held 1 earlier board appointment: Suchirayu Health Care Solutions Limited (Nominee Director, 18 Nov 2021 to 30 Jun 2025).
The current boards of Anjali Rossi Ajaikumar's companies include Akshay Tanna (Healthcare Global Enterprises Limited), Basavalinga Ajaikumar Sadasivaiah (Healthcare Global Enterprises Limited), Bijou Kurien (Healthcare Global Enterprises Limited), Geeta Mathur (Healthcare Global Enterprises Limited), Manish Mattoo (Healthcare Global Enterprises Limited), Manish Mattoo (Healthcare Global Enterprises Limited), among others.